ticker,published_utc,title,publisher,url
NTLA,2025-11-12T22:02:40+00:00,Tracking Cathie Wood's ARK Invest 13F Portfolio - Q3 2025 Update,SeekingAlpha,https://finnhub.io/api/news?id=e40ec65ff111700464629f15fa3b413b2a2a5176dbc6bda627c5aa446e6bd8ee
NTLA,2025-11-07T05:46:11+00:00,"Intellia Therapeutics, Inc. (NTLA) Q3 2025 Earnings Call Transcript",SeekingAlpha,https://finnhub.io/api/news?id=2ebdfe720d7dc2f2fe1bf5b1e776d2051d584b873558f2b020561df6b8956fb1
NTLA,2025-11-04T15:41:00+00:00,"Vertex Q3 Earnings Beat, Stock Down as Casgevy Sales Disappoint",Yahoo,https://finnhub.io/api/news?id=ab681250ae6f60113c5c943a46dfd2db1f35ef5da0629788493df8f4832b019a
NTLA,2025-11-04T15:28:00+00:00,"AXSM Q3 Loss Wider Than Expected, Revenues Surge Y/Y on Auvelity Sales",Yahoo,https://finnhub.io/api/news?id=2e8f25ffe22557482c296731ab62de8ae282291d090af1057b61d73155dd7898
NTLA,2025-11-04T15:26:00+00:00,"TGTX's Q3 Earnings & Revenues Trump Estimates, 2025 View Raised",Yahoo,https://finnhub.io/api/news?id=3581f61beda69f5d9d1d501a18ffb9f867123786801503dd03e61289ee346b42
NTLA,2025-11-03T15:11:00+00:00,Should CRSP Stock Be in Your Portfolio Pre-Q3 Earnings?,Yahoo,https://finnhub.io/api/news?id=f7425465ccfeaffc359080d622b8c5bbc3d5a7929370b5e117954ac0d00367c4
NTLA,2025-11-02T14:25:00+00:00,Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More Than 130%,Yahoo,https://finnhub.io/api/news?id=ba9b0bee4c6cbfa06102c2dc91c7f889494c80f43ae6ad1ce706c367a7ec3cc0
NTLA,2025-10-31T17:44:00+00:00,"AGIO's Q3 Loss Narrower Than Expected, Pyrukynd Drives Y/Y Revenues",Yahoo,https://finnhub.io/api/news?id=23535bcdea2ed2eff1c5342d424cba47a63cc52dbe0033e9f43cf7d3844e1257
NTLA,2025-10-31T14:00:03+00:00,ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release,Yahoo,https://finnhub.io/api/news?id=e5dcc97ad05cd430907b5107ab5c485b5ac0d8c5f90158c606e9b8e67cd7ff52
NTLA,2025-10-31T11:58:08+00:00,Intellia Therapeutics: Irreversible Edit Vs. Reversible SOCs Now A Hard Sell (Rating Downgrade),SeekingAlpha,https://finnhub.io/api/news?id=91ebd41d21c6946c67154ec40b603dc66e2cb89944a84837829e8054cd2f955e
NTLA,2025-10-30T15:43:05+00:00,Intellia: Moving To 'Hold' Rating In Light Of Nex-Z Uncertainty In ATTR Patients (Downgrade),SeekingAlpha,https://finnhub.io/api/news?id=858a24e335726b5f77fbe0b6c129cf651d28febd09d1261563e9a5085c6f9fbe
NTLA,2025-10-30T10:54:00+00:00,FDA places formal hold on two Intellia CRISPR trials,Yahoo,https://finnhub.io/api/news?id=3b0c7d87d008b9c3f8d91627c5d82bc293e909e0f3264e85c955d017c368a615
NTLA,2025-10-29T17:57:44+00:00,Assessing Intellia Therapeutics After a 48% Price Drop and Clinical Updates in 2025,Yahoo,https://finnhub.io/api/news?id=d0f00cf92be2e7e263e086e505d72efa16dc299e35942f800b7a8be7e1316b63
NTLA,2025-10-29T07:18:11+00:00,Why The Narrative Around Intellia Therapeutics Is Shifting After Safety Concerns and Trial Pauses,Yahoo,https://finnhub.io/api/news?id=ccf1af91d6f9dcb9f34294b677e2ead9c8935b46405468199afaad1ac5108e27
NTLA,2025-10-28T21:09:18+00:00,Intellia Therapeutics (NTLA) Is Down 45.2% After Pausing Key Nex-z Trials Over Safety Issue – Has The Bull Case Changed?,Yahoo,https://finnhub.io/api/news?id=72a3bb09b95a1ab72be77f5185dd42a292d59cce7ab3d3f135717b50475c4f36
NTLA,2025-10-28T18:09:11+00:00,Intellia Therapeutics (NTLA): Evaluating Valuation After Phase 3 Gene-Editing Trial Halt and Share Price Drop,Yahoo,https://finnhub.io/api/news?id=fdc61f91d012b801197b3ce233782b9ffb7db99386f05629131e9913821642f4
NTLA,2025-10-28T16:43:12+00:00,CRISPR Crisis: Intellia Stock Crashes 40% After Shock Trial Pause,Yahoo,https://finnhub.io/api/news?id=12d8861bea17ffa044cf5f734c8dffecb37bd051a3bdf58ef8ef4fb3388c8e22
NTLA,2025-10-28T15:16:03+00:00,"Intellia Therapeutics' Liver Toxicity Claim in Phase 3 Trials 'Unconvincing,' RBC Says",Yahoo,https://finnhub.io/api/news?id=da08b684f789d34ba155104c6431d8da6107cc1297ef8a916602850d2aac30f1
NTLA,2025-10-28T13:42:32+00:00,"Warner Bros. Discovery upgraded, F5 downgraded: Wall Street's top analyst calls",Yahoo,https://finnhub.io/api/news?id=1d71bc7629e2ab2ed03d3641282ecc5a78ac28b5d2b97e73714458d210a036a3
NTLA,2025-10-27T19:57:13+00:00,Sector Update: Health Care Stocks Increase Late Afternoon,Yahoo,https://finnhub.io/api/news?id=240ce631e1db7258fc39841cc3d4aeae2bab389b97a7fd7d58784216f4b7dd8b
NTLA,2025-10-27T18:56:37+00:00,Top Midday Decliners,Yahoo,https://finnhub.io/api/news?id=202dd61cc17d6127cfacf612d4de069663a2a3d073317b221a40917f8d397b5d
NTLA,2025-10-27T17:48:11+00:00,Sector Update: Health Care Stocks Softer Monday Afternoon,Yahoo,https://finnhub.io/api/news?id=fa00f8fad1a4730c2b3dbf9134822fda97b7a5ff994fc060525fd0980b8cc329
NTLA,2025-10-27T16:03:00+00:00,Intellia Therapeutics Stock Drops as Safety Fears Emerge in Drug Trial,Yahoo,https://finnhub.io/api/news?id=0532335a327feb18874c46c311864a47a4d46a3ce51288f4ca7ee33e158e2b08
NTLA,2025-10-27T12:25:55+00:00,Intellia stock tumbles after pausing gene therapy trials on safety concerns,Yahoo,https://finnhub.io/api/news?id=4306ecad734d90a2f12be7868f6dd27e84440d7afbaa2496b1006b5489f379dc
NTLA,2025-10-27T12:00:00+00:00,Intellia pauses two CRISPR drug studies after safety scare,Yahoo,https://finnhub.io/api/news?id=6cf9a1fc955b7c55c3ed4933ab6ca0d6f90c3a974588e4b5e68ba5966c29d2bf
NTLA,2025-10-27T11:30:00+00:00,Intellia Therapeutics Provides Update on MAGNITUDE Clinical Trials of Nexiguran Ziclumeran (nex-z),Yahoo,https://finnhub.io/api/news?id=534aebe19b3ae255703a9366cfcb02c376f5a5fe0868cce59b621db8c7f867ba
NTLA,2025-10-27T11:17:54+00:00,"Intellia Therapeutics, Inc. (NTLA) Discusses Safety Event and Protocol Pause in MAGNITUDE Clinical Trials of Nex-Z Transcript",SeekingAlpha,https://finnhub.io/api/news?id=f29ec3f0307249de7f35331453706cdc4d14ac4fbf0807bf4c1f3bf7affe5c8a
NTLA,2025-10-24T08:15:19+00:00,Crispr And Intellia: Advancing In Vivo Gene Editing As 2025 Results Strengthen Investment Outlook,SeekingAlpha,https://finnhub.io/api/news?id=342f619056e89900f1000983900304cd255142067db050b0af382209531f7b61
NTLA,2025-10-21T16:56:26+00:00,Intellia (NTLA) Soars 13% to Fresh High,Yahoo,https://finnhub.io/api/news?id=8c4911bd357f6e9c190d160d200dad507c6c50546c734d24aa63d9c47ebfd394
NTLA,2025-10-18T00:30:00+00:00,Q3 2025 Review: Bears Capture Headlines While Bulls And Gold Bugs Garner Profits,SeekingAlpha,https://finnhub.io/api/news?id=5a97644c72e1fe31f91a94a033fe24f3ba801aab718ef69ae4ced50dd7039d9b
NTLA,2025-10-13T01:05:21+00:00,What Recent Gene Editing Breakthroughs Mean for the Future of Intellia Therapeutics Stock,Yahoo,https://finnhub.io/api/news?id=bdbbdd9d30df30b0c7f5c7667ac4205857eaf1ccb373c29e0e5455ae1fedc950
NTLA,2025-10-12T14:06:49+00:00,Why Intellia Therapeutics (NTLA) Is Up 22.8% After Promising Gene-Editing Data at ESGCT 2025 and Phase 3 Enrollment,Yahoo,https://finnhub.io/api/news?id=5f69d97c4f2a43e9c7ed5776426a928dda6c1d80e7e58d8437ce421adc2cea51
NTLA,2025-10-12T12:06:20+00:00,A Look at Intellia Therapeutics’s Valuation Following Breakthrough ATTR Data and HAELO Study Milestone,Yahoo,https://finnhub.io/api/news?id=f712756d543e728385099a3f04412c6381641564be2e6b3b8b8fc0f7291fc654
NTLA,2025-10-09T13:23:00+00:00,Intellia Therapeutics (NTLA) Soars 19.7%: Is Further Upside Left in the Stock?,Yahoo,https://finnhub.io/api/news?id=96a5e653500078e645f533c1fde6f83110810927852233776d7f285d90df489d
NTLA,2025-10-09T08:59:22+00:00,Intellia Therapeutics (NTLA) Soars to New High as Analysts Trigger ‘Buy’,Yahoo,https://finnhub.io/api/news?id=88e6375a16f44788ab8a52c9981af86ee6220c6cc3846ae88b2b9508d7eab97b
NTLA,2025-10-08T21:31:00+00:00,Hereditary Transthyretin Amyloidosis Market Forecasts Strong Growth Amid New Treatment Launches | DelveInsight,Yahoo,https://finnhub.io/api/news?id=2781af7ab22a2389d58f5482a4a103c2527b44357982e6dada9ba1aa0b1aee2a
NTLA,2025-10-08T16:00:04+00:00,Intellia Therapeutics (NTLA) Upgraded to Buy: Here's What You Should Know,Yahoo,https://finnhub.io/api/news?id=04f035f1ff1c3e6d4605061a9473790885ac6d4bbac9e93a6990f8ef75ec5db8
NTLA,2025-10-08T13:55:01+00:00,Wall Street Analysts Predict a 63.7% Upside in Intellia Therapeutics (NTLA): Here's  What You Should Know,Yahoo,https://finnhub.io/api/news?id=def1361c026187ee71ec34112f4fa09b8ee5bd34b78d7ccba50570d51ee2c8af
NTLA,2025-10-08T13:40:03+00:00,Is Intellia Therapeutics (NTLA) Outperforming Other Medical Stocks This Year?,Yahoo,https://finnhub.io/api/news?id=c874c070768a7bec3c0d23e172b50e29c1eff9efff54058000a9a1aeb2a5f604
NTLA,2025-10-07T13:45:00+00:00,"1 Stock Up by 63% This Year That Could Double, According to Wall Street",Yahoo,https://finnhub.io/api/news?id=c0d8a7324d78968da47e7fc596966a76459e67faf99c568521c8a33bc64821b6
NTLA,2025-10-03T20:01:00+00:00,Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),Yahoo,https://finnhub.io/api/news?id=967cf28dfb12e59b799815b3c3726f13556537bfc81f722cb79c10e9b3298b47
NTLA,2025-10-01T14:47:00+00:00,Cathie Wood Goes Shopping: 3 Rising Stocks She Just Bought,Yahoo,https://finnhub.io/api/news?id=20b852977a93ff98e2bbdac52c6bb7700a7cf568ae79111b1cd6b01a83603ee8
NTLA,2025-09-28T11:05:07+00:00,How Investors May Respond To Intellia Therapeutics (NTLA) Reporting Three-Year Data on Gene-Editing Therapy,Yahoo,https://finnhub.io/api/news?id=567ab55f11ed8f8a624a0f7510d32279170e058ca7364903eb00b7bc2991c76f
NTLA,2025-09-27T13:32:50+00:00,Reassessing Intellia Therapeutics (NTLA): Valuation Insights After New Three-Year Nex-z Clinical Data and Ongoing Phase 3 Progress,Yahoo,https://finnhub.io/api/news?id=e3cc6a57e46b8c096aa98226f9a1740475e224f64ab0b17725bee9d9d43f8c94
NTLA,2025-09-25T17:57:31+00:00,Intellia Highlights Clinical Improvements With One-Time Dose Of Experimental Drug,Yahoo,https://finnhub.io/api/news?id=845b0c6bb3b78b1519f2301ba4e21b9a0ce6d788cac342224848c3f2a8760f8c
NTLA,2025-09-25T13:52:00+00:00,Intellia Therapeutics Announces Positive Longer-Term Phase 1 Data for Nexiguran Ziclumeran (nex-z) in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy,Yahoo,https://finnhub.io/api/news?id=a5ac698ba9d5fdecc6a3e44e75919d52dd3d335ec7c98846b8e43a5ba423e8aa
NTLA,2025-09-22T11:30:00+00:00,Intellia Therapeutics to Present Longer-Term Data from the Ongoing Phase 1 Clinical Trial of Nexiguran Ziclumeran (nex-z) for the Treatment of Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy,Yahoo,https://finnhub.io/api/news?id=73f437d735901eeb104606691f294e114b5047d9fccbff95fd1da425114b55c6
NTLA,2025-09-19T17:24:00+00:00,"NTLA Completes Enrollment in Pivotal Study on HAE Candidate, Stock Up",Yahoo,https://finnhub.io/api/news?id=e70dfe42ab5dbe42e8c0c2c781b7b552d6cdd4e8e85416636fcc80f9a07075ea
NTLA,2025-09-19T14:31:31+00:00,Intellia Therapeutics: Full Trial Enrollment Wows Market - Underlines Buy Thesis,SeekingAlpha,https://finnhub.io/api/news?id=b85c80e0df6997aa5678e952b2ba1e2b82b526d6b1d99af27498a05e9bb016d2
NTLA,2025-09-19T14:20:00+00:00,Strength Seen in Intellia Therapeutics (NTLA): Can Its 29.8% Jump Turn into More Strength?,Yahoo,https://finnhub.io/api/news?id=07adb3ecc7f050c959b5ab5e84a77d988a825a7f3e99ead8b1ef7d0d79f612ce
NTLA,2025-09-18T12:30:00+00:00,Intellia Therapeutics Completes Enrollment in the Global Phase 3 HAELO Study of Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema,Yahoo,https://finnhub.io/api/news?id=e7ffef9df4c634d18985e20caaa5ecb7b66f8ba5d969d85c58dff66bf4a128b2
NTLA,2025-09-10T16:30:05+00:00,Why Is Xenon Pharmaceuticals (XENE) Up 4.2% Since Last Earnings Report?,Yahoo,https://finnhub.io/api/news?id=1078b825f401e5d573832fa8f8daa02cb01cccba8bed34f575d171afd1f43aec
NTLA,2025-09-02T20:46:46+00:00,Cathie Wood Pours $4 Million Into This High-Growth Biotech Stock,Yahoo,https://finnhub.io/api/news?id=49e1ae6bba4703f841cd98572622dac0e2ce3ba0fb38175f78605d78293b8dc9
NTLA,2025-08-29T14:22:00+00:00,Can CRSP's In Vivo Pipeline Aid Long-Term Growth Beyond Casgevy?,Yahoo,https://finnhub.io/api/news?id=971e42183b0a3ae954f53d433b958604452fd640f7e5d38af7326af6f71e751e
NTLA,2025-08-21T15:15:00+00:00,CRISPR Therapeutics Gains 41.4% in 3 Months: How to Play the Stock,Yahoo,https://finnhub.io/api/news?id=2c15ba78ae1b15d0aab44ccd3993e3f60805a73d176a8d25ac9ff362c9564b66
NTLA,2025-08-21T14:59:38+00:00,Cathie Wood Is Betting Big on Intellia Therapeutics. Should You Buy NTLA Stock Here?,Yahoo,https://finnhub.io/api/news?id=4bd688f46a2518c07929e137e5c8f4a3716ba5d66bf408de2fa29d2fa5e79cb5
NTLA,2025-08-15T12:24:05+00:00,Intellia Therapeutics: It May Be Time To Get Excited And Buy (Upgrade),SeekingAlpha,https://finnhub.io/api/news?id=759b1eabf2cf8bbfd97f848c7f433566054302a346e6a178f4f10845d392ad1e
NTLA,2025-08-12T15:40:00+00:00,Can Rising Casgevy Sales Aid CRISPR Therapeutics Post Q2 Earnings?,Yahoo,https://finnhub.io/api/news?id=55ee33929aa207ff23b4d15737c8e717b0136021cdc952fcc3b337462263c97d
NTLA,2025-08-11T18:40:34+00:00,"Analysts Are Upgrading Intellia Therapeutics, Inc. (NASDAQ:NTLA) After Its Latest Results",Yahoo,https://finnhub.io/api/news?id=3c0384fe4b2058d707b20294532c632710244addbdfd7833c2ea62e16f0c628a
NTLA,2025-08-09T14:38:44+00:00,Intellia Therapeutics Second Quarter 2025 Earnings: Beats Expectations,Yahoo,https://finnhub.io/api/news?id=f84867989ab1d0f979122cd97c0ac45883c99a5b9061e6a348874b7bd6dc6ccc
NTLA,2025-08-08T15:19:00+00:00,"Intellia Q2 Loss Narrower Than Expected, Pipeline Progress in Focus",Yahoo,https://finnhub.io/api/news?id=a43a37cd0dcbd36152114259bd1ec98a3f75b3bc8b425fb159f6dabfbce7a1e8
NTLA,2025-08-08T10:05:00+00:00,"Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Pipeline Market Research 2025 | Key Players Include Intellia Therapeutics, Renowned for NTLA-2001 in Phase III Development, Leveraging CRISPR/Cas9",Yahoo,https://finnhub.io/api/news?id=e6631671d1057d0cea837d0b76233000c63906ed6d5577df67ab10c824e162b5
NTLA,2025-08-07T21:09:12+00:00,Tracking Cathie Wood's ARK Invest 13F Portfolio - Q2 2025 Update,SeekingAlpha,https://finnhub.io/api/news?id=6caa4ec0c6fc26248681e85852a1351f845c7816fb01e66e7e4792b2b3998d0e
NTLA,2025-08-07T20:17:28+00:00,"Intellia Therapeutics, Inc. (NTLA) Q2 2025 Earnings Call Transcript",SeekingAlpha,https://finnhub.io/api/news?id=e6bcf038dd63047c77ea0660abeba601fae8997b4780f16bd62dcaaf2519bb0c
NTLA,2025-08-07T12:40:03+00:00,"Intellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Beats Revenue Estimates",Yahoo,https://finnhub.io/api/news?id=203576668e20ecff8063ecf7ece87974777afc5d1dbc6d6ff4ecfe293a841608
NTLA,2025-08-07T11:30:00+00:00,Intellia Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Company Progress,Yahoo,https://finnhub.io/api/news?id=43c3c317fe1822161730ac3f934d3c139952dbb00e50a8302aea913c8d1e7ec7
NTLA,2025-07-31T17:12:00+00:00,BioCryst Pharmaceuticals Before Q2 Earnings: How to Play the Stock,Yahoo,https://finnhub.io/api/news?id=7cd846329bf385b0826ad452728d4b960e1dbafe644c2475d70608136792d5fa
NTLA,2025-07-31T11:30:00+00:00,Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2025 Earnings and Company Updates,Yahoo,https://finnhub.io/api/news?id=10d8d6c356fa76b50ef4aede3361fd548edb70fd02e2f708c8a5c241abe3ebc1
NTLA,2025-07-30T13:44:00+00:00,3 Genomics Stocks Worth Adding to Your Portfolio in 2025,Yahoo,https://finnhub.io/api/news?id=447506e1b916b6b3378a73ec8e9f910c39026524a22f29e76786fed0f687e6b0
NTLA,2025-07-18T08:00:00+00:00,"With Intellia Therapeutics, Human Patience Beat Hot-Take Trading: Still At 'Buy'",SeekingAlpha,https://finnhub.io/api/news?id=e6ac3af8cbacdc08db36e97da9a93e8fa344e258894b1f28a93e45da5142a5c3
NTLA,2025-07-15T15:24:45+00:00,Astria: Betting On Navenibart In The Crowded HAE Arena,SeekingAlpha,https://finnhub.io/api/news?id=ed2a44ff0fc36b261843f25a2b073d13bd451bbcfafa9ccb6699bda19081bb1c
NTLA,2025-07-08T16:54:19+00:00,The Next Moderna? This Clinical-Stage Biotech Has Breakout Potential.,Yahoo,https://finnhub.io/api/news?id=ab8320d7b666ba7ac8033fc7d630297800a0a8c073a5ca3acb7fde0a0e8241ac
NTLA,2025-07-07T13:46:00+00:00,Intellia Gains 29.8% in a Month: How Should You Play the Stock?,Yahoo,https://finnhub.io/api/news?id=6386b7f23af3aa0e49534700ec1d95176e97cbb4a803c19ee3fecc9a8c7d56d2
NTLA,2025-07-03T13:18:36+00:00,Citizens JMP Maintains Neutral Stance on Intellia Despite Positive Lonvo-z Data,Yahoo,https://finnhub.io/api/news?id=a034949405134842f4eff580b9a2b170b8f7a4c09c1029e2380be7a4d86ac2d4
NTLA,2025-06-27T12:03:00+00:00,3 Promising Genomics Stocks to Keep an Eye On in 2025,Yahoo,https://finnhub.io/api/news?id=70d2c30877054e6aa4102d86513a7775ae41d67db440c5d700c421a0a3247376
NTLA,2025-06-25T14:03:00+00:00,CRISPR Therapeutics vs. Intellia: Which Gene Editing Stock Holds More Potential?,Yahoo,https://finnhub.io/api/news?id=80e91f10b910bf0a4c9b52a5eac8b15b7722faeffb1530fc27a57548314eaea2
NTLA,2025-06-23T05:41:49+00:00,Intellia Reports Positive 3-Year Lonvo-z Data in HAE Trial at EAACI Congress,Yahoo,https://finnhub.io/api/news?id=d738863cc9387ee401e8e6dccbc64b3472e641178f603cee965d5298ad552857
NTLA,2025-06-21T12:35:17+00:00,Will Intellia Therapeutics (NASDAQ:NTLA) Spend Its Cash Wisely?,Yahoo,https://finnhub.io/api/news?id=4ff89f9d36e15749ba5985865b86ecf249a3f0de8b3e79cf478d8adbf1898e38
NTLA,2025-06-18T13:35:00+00:00,Gene-Editing Stocks Gain on LLY-VERV Deal Announcement,Yahoo,https://finnhub.io/api/news?id=0e5e497a13ebc0a5849ce40d27b13c4116ceec96870181d53d6d43407edb73c5
NTLA,2025-06-17T17:32:12+00:00,"Intellia Therapeutics, Inc. (NTLA) Backed by H.C. Wainwright for 237% Upside Potential",Yahoo,https://finnhub.io/api/news?id=7bd3ca18401eed0895dc4cefd4517f93e65b1e9bb4acc11bf26c8672fb27b5f8
NTLA,2025-06-17T13:14:27+00:00,Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover,Yahoo,https://finnhub.io/api/news?id=e87a13020c8421c0a00c63523902c62c950d416f45bd309a7d3fa45918a49ab0
NTLA,2025-06-16T09:17:28+00:00,Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran in Patients with Hereditary Angioedema at the European Academy of Allergy and Clinical Immunology Congress,Finnhub,https://finnhub.io/api/news?id=73e90cc9735e7b44c1bca5f9658ac90068e9aaebeb2000b04cbdbcd742f5ef1f
NTLA,2025-06-15T14:45:00+00:00,Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema (HAE) at the European Academy of Allergy and Clinical Immunology Congress,Yahoo,https://finnhub.io/api/news?id=99d3e10722b9a4278fe54e3eef16a7f7dfe1e5d202aaca6390626247e509891c
NTLA,2025-06-04T14:58:00+00:00,BEAM Up on FDA's Orphan Drug Status for Gene-Editing Therapy,Yahoo,https://finnhub.io/api/news?id=9a115b9cca7a6503109e599634cc7a760e9a0d251534f0a6d85c6c8167aa6dce
NTLA,2025-06-04T13:55:09+00:00,How Much Upside is Left in Intellia Therapeutics (NTLA)? Wall Street Analysts Think 398.31%,Yahoo,https://finnhub.io/api/news?id=b4de9ab2c7035566549f2c7cf3e77b4d97e76184d6e1d85f8b036519a92ed3bf
NTLA,2025-06-04T12:55:00+00:00,Can CRISPR Build on Casgevy's Success With Its In Vivo Pipeline?,Yahoo,https://finnhub.io/api/news?id=96dadd5ed3853f7829ac7ffa224bece4302c9935df75deb2335008e1b1461556
NTLA,2025-05-30T14:20:00+00:00,NTLA Stock Down as Patient Faces Adverse Event in Gene Therapy Study,Yahoo,https://finnhub.io/api/news?id=5207decdb6366347d384ae31b0c50ca394159b7ce76201b195f571edb70a03f5
NTLA,2025-05-30T09:56:56+00:00,Intellia stock dips following safety event in Phase III gene therapy trial,Yahoo,https://finnhub.io/api/news?id=29c4cfeaed176a5c58a2855e45e8816cbb7e9a19c49037c31f9cb11ba1fdd20e
NTLA,2025-05-29T14:25:10+00:00,Intellia: Heart Disease Safety Setback Triggers Selloff - Caution Advised,SeekingAlpha,https://finnhub.io/api/news?id=7c3dc274d59fe51498aa255157423d647b8db62d528dac9aae055ee7f328b241
NTLA,2025-05-29T12:18:51+00:00,Intellia stock tumbles on safety concerns,Yahoo,https://finnhub.io/api/news?id=094e226b68847094f5fac4a84ca330ea6789564a83060a0ab9ab0ba4f8e1e44f
NTLA,2025-05-29T11:16:00+00:00,Intellia filing spurs safety concerns over CRISPR drug,Yahoo,https://finnhub.io/api/news?id=0b5e029ee1a6d878b2f3bbb81b9f850f51c891ce0a06bb2a6161d90280d4f861
NTLA,2025-05-20T05:47:34+00:00,I Missed The Quantum Rally - I Won't Miss The Next One,SeekingAlpha,https://finnhub.io/api/news?id=5d72638ddfbdde7582ee7f1b1af02b8f81397ae1f8ac9a7a7b6845cf6092ecb4
NTLA,2025-05-19T09:24:13+00:00,"Intellia Announces Positive Two-Year Follow-Up Data from Ongoing Phase 1 Study of Nexiguran Ziclumeran, in Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy at Peripheral Nerve Society Annual Meeting",Finnhub,https://finnhub.io/api/news?id=93fe95b8512ea74ed99e2b51ea207809327dbeb7ffe8b5d9c37982ba978666c9
NTLA,2025-05-18T11:25:00+00:00,"Intellia Announces Positive Two-Year Follow-Up Data from Ongoing Phase 1 Study of Nexiguran Ziclumeran (nex-z), in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy at Peripheral Nerve Society Annual Meeting",Yahoo,https://finnhub.io/api/news?id=4ca0e8a3e17ae620441b64c96ed006a4ed3bd05cd75a7a8603410c78708ac4f0
NTLA,2025-05-15T13:55:07+00:00,Wall Street Analysts See a 408.63% Upside in Intellia Therapeutics (NTLA): Can the Stock Really Move This High?,Yahoo,https://finnhub.io/api/news?id=489e7a3798439a85e4c1f56106c17c04914e2f79b22d8dedc385510f374ce8c7
NTLA,2025-05-14T13:57:08+00:00,"Intellia Therapeutics, Inc. (NTLA) BofA Securities 2025 Healthcare Conference (Transcript)",SeekingAlpha,https://finnhub.io/api/news?id=dc63e45397b78d5d95a1ecbb3f57c71629c358f1787c416e9897755cc89fbd78
NTLA,2025-05-13T22:05:24+00:00,"Transcript : Intellia Therapeutics, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 04",Finnhub,https://finnhub.io/api/news?id=cc034fcef86b08bcc2d4358058c5e601a4af68173047603c38eca1e8b1bb3be4
NTLA,2025-05-12T09:07:07+00:00,"Intellia Therapeutics Shares Have Struggled, But It's Now Go-Time (Rating Upgrade)",SeekingAlpha,https://finnhub.io/api/news?id=bf5a19b9503d8c1b16498ed8d6a2dadb4f43a3fbdd59d3d68c10be5e2919c31f
NTLA,2025-05-11T12:42:36+00:00,"Analyst Estimates: Here's What Brokers Think Of Intellia Therapeutics, Inc. (NASDAQ:NTLA) After Its First-Quarter Report",Yahoo,https://finnhub.io/api/news?id=48038a0f718e135763a9aeb7d682e9ad25df9ac1a5bc59ebd4b2e484cd1d3069
NTLA,2025-05-10T12:34:03+00:00,"News Flash: Analysts Just Made An Upgrade To Their Intellia Therapeutics, Inc. (NASDAQ:NTLA) Forecasts",Yahoo,https://finnhub.io/api/news?id=2dea213d8bad0c17fc5f392b7621de624f29def61ba2561ff496d4331bdbc6d2
NTLA,2025-05-09T16:25:00+00:00,"Intellia's Q1 Loss Narrower Than Expected, Pipeline in Focus, Stock Up",Yahoo,https://finnhub.io/api/news?id=9763f7753260ad136a416813c71adfe03efc30ab82bb6e7afd9969a77dc9fd8d
NTLA,2025-05-09T07:12:32+00:00,Intellia Therapeutics Inc (NTLA) Q1 2025 Earnings Call Highlights: Strategic Advancements Amid ...,Yahoo,https://finnhub.io/api/news?id=8a663d80f44164ff009fa6e48142145d33b6f857fbdb347255bd92b7e5f42e7d
NTLA,2025-05-08T20:16:14+00:00,Tracking Cathie Wood's ARK Invest 13F Portfolio - Q1 2025 Update,SeekingAlpha,https://finnhub.io/api/news?id=c9c02232461994cc8e615e222329fa9f169204b87bad926bc80ed2631390a3bc
NTLA,2025-05-08T12:45:08+00:00,"Intellia Therapeutics, Inc. (NTLA) Reports Q1 Loss, Tops Revenue Estimates",Yahoo,https://finnhub.io/api/news?id=dce7d70872a0a25f970313e5773a665b6ccd80083769114189231b1a594b5ebe
NTLA,2025-05-08T11:37:08+00:00,"Intellia Therapeutics, Inc. (NTLA) Q1 2025 Earnings Call Transcript",SeekingAlpha,https://finnhub.io/api/news?id=10a25f6943411a8acaef0f749f1a7ec2ad6ecf2005e843116a5611ed8d7f58f3
NTLA,2025-05-08T11:30:00+00:00,Intellia Therapeutics Announces First Quarter 2025 Financial Results and Highlights Recent Company Progress,Yahoo,https://finnhub.io/api/news?id=44e073c4cc3ed8224879caff81865ef983c76063827253383cae826fae9d440e
NTLA,2025-05-08T07:45:00+00:00,"Intellia Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025",Finnhub,https://finnhub.io/api/news?id=b863139ac40a226d26380f8af533e7dc33c0cbb344ba95e799ca0ef08440643c
NTLA,2025-05-06T12:40:04+00:00,CorMedix (CRMD) Surpasses Q1 Earnings and Revenue Estimates,Yahoo,https://finnhub.io/api/news?id=9aa5de1398d4e1baec634cf1581f2490c3fb726bff0da93cbce0c798772f58c2
NTLA,2025-05-05T14:00:21+00:00,"Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?",Yahoo,https://finnhub.io/api/news?id=a5d1a2b93415275f57479edc15b6b495e06b5b2a8bfd7268fe86047be21fb5e8
NTLA,2025-05-05T04:44:56+00:00,CRISPR Therapeutics And Intellia Therapeutics: Balancing Market Uncertainty Against Pipeline Catalysts,SeekingAlpha,https://finnhub.io/api/news?id=c3e2cd5c08e868d6823d9a2dffcfbbd2e24a2da1fbb8bb813c825b626f36f2fc
NTLA,2025-05-02T09:06:49+00:00,Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2025 Earnings and Company Updates,Finnhub,https://finnhub.io/api/news?id=79bb6165d4b46a73944a4cffdc43405acfbf96ddcc3daa7b81e31d6d88ab180c
NTLA,2025-05-01T14:01:38+00:00,"Earnings Preview: Intellia Therapeutics, Inc. (NTLA) Q1 Earnings Expected to Decline",Yahoo,https://finnhub.io/api/news?id=e800f0d319a71f28177f30c805b305325ba250057cf8d7618a1c16a6caf127c1
NTLA,2025-05-01T13:30:02+00:00,"Intellia Therapeutics, Inc. (NTLA) Recently Broke Out Above the 50-Day Moving Average",Yahoo,https://finnhub.io/api/news?id=bbbdcecd401fc1901f71a2f6af836324748b897f64aa3392f90e1e244f1a1f81
NTLA,2025-05-01T11:30:00+00:00,Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2025 Earnings and Company Updates,Yahoo,https://finnhub.io/api/news?id=959fdc5967e036887df06af7ef71c7318e36df96e3ce7940d21acb7d32792403
NTLA,2025-05-01T07:30:00+00:00,"Transcript : Intellia Therapeutics, Inc., Q1 2025 Earnings Call, May 08, 2025",Finnhub,https://finnhub.io/api/news?id=c6e07d60aadb5091f74d55de8cd6cdb0445d6c186bb04e853afaf266d34270d5
NTLA,2025-04-30T14:15:00+00:00,Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought,Yahoo,https://finnhub.io/api/news?id=8bae11a77da9c74a53538d77fc8a17e0409e13edd1df8af30ce81578e2a70dd8
NTLA,2025-04-29T13:55:06+00:00,Wall Street Analysts Think Intellia Therapeutics (NTLA) Could Surge 392.81%: Read This Before Placing a Bet,Yahoo,https://finnhub.io/api/news?id=7a141f9afe37e7bd6c087db38a769d18a4ffd1f4ba530cdc8d23a2df08b7a82e
NTLA,2025-04-23T09:51:04+00:00,"Lawsuit for Investors in shares of Intellia Therapeutics, Inc. (NASDAQ: NTLA) announced by the Shareholders Foundation",Finnhub,https://finnhub.io/api/news?id=b6b6dcbb42c65982a5c96e7bb2aebbaecf61f83adbec7cfb10539d91b352a291
NTLA,2025-04-22T09:30:00+00:00,Trump’s FDA Sends a Bullish Signal to Biotech,Yahoo,https://finnhub.io/api/news?id=ba118c9557e5c607e504508703096445d98e7e53892248f464d134a5a924f8a7
NTLA,2025-04-21T20:09:20+00:00,Why Sarepta Therapeutics And Other Genetics Stocks Just Got A Sizable Boost,Yahoo,https://finnhub.io/api/news?id=f2d649b981020e33c08953ab036fd2ba6e38602080f0b3e42e09884998d14f14
NTLA,2025-04-14T16:15:16+00:00,"Pomerantz Law Firm Reminds Investors with Losses on their Investment in Intellia Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - NTLA",Finnhub,https://finnhub.io/api/news?id=3ab7d64751d1d6fea377d9b14b0b5078c33dde6325448059293a819c0edaaaf5
NTLA,2025-04-14T11:36:03+00:00,"NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm",Finnhub,https://finnhub.io/api/news?id=024b1546d09a5a9bd78d057110491caa5650ee9c8be0faf559cbd9e711d556e3
NTLA,2025-04-14T10:59:05+00:00,"Final Deadline Today for the Intellia Therapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - NTLA",Finnhub,https://finnhub.io/api/news?id=85b9166e474e6729bdf505e8dfebf47fc0f2be1063691371ce40ed3b9b9665f7
NTLA,2025-04-14T10:14:03+00:00,"FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics",Finnhub,https://finnhub.io/api/news?id=ddd151f18972c959526dc586eafb161b3e43e8a3274b9150bb2d220b5d9741b0
NTLA,2025-04-14T08:54:04+00:00,"NTLA Investors are Reminded of the Final Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm",Finnhub,https://finnhub.io/api/news?id=7ba3fc44ede2376de8d7a5c97caa4325ceedc467bd79de732adf45ca77055bbf
NTLA,2025-04-13T17:15:05+00:00,"NTLA Deadline: NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit",Finnhub,https://finnhub.io/api/news?id=5116ede5bae47c8f308ba5dfdb94432c266eada1e290a8fd9c6c46066a42e20a
NTLA,2025-04-11T17:29:03+00:00,"NTLA DEADLINE MONDAY: ROSEN, A LEADING LAW FIRM, Encourages Intellia Therapeutics, Inc. Investors with Losses in Excess of $50K to Secure Counsel Before Important April 14 Deadline in Securities Class Action - NTLA",Finnhub,https://finnhub.io/api/news?id=aaab1731d8371bf1f6623685189b29acf5e5f4c217e459dbe7b24252b114b95f
NTLA,2025-04-11T12:03:03+00:00,"NTLA Deadline: Rosen Law Firm Urges Intellia Therapeutics, Inc. (NASDAQ",Finnhub,https://finnhub.io/api/news?id=02f073bb9e28806a9ad6daa47b775d9ff960d3e0ffb1166ffe5f42e8d43345d1
NTLA,2025-04-11T05:46:21+00:00,"Intellia Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights - NTLA",Finnhub,https://finnhub.io/api/news?id=f4eb40b32a34534ef01f5c12f002971f1f2ea96259ca7fc169b74983b3555d17
NTLA,2025-04-10T10:41:05+00:00,"SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics",Finnhub,https://finnhub.io/api/news?id=5a365d3b4e717eee9457e608db5a8aea4459ae905f1e5b391969880a3c812880
NTLA,2025-04-10T05:46:22+00:00,"The Gross Law Firm Notifies Intellia Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - NTLA",Finnhub,https://finnhub.io/api/news?id=9008b63d2c7e25330b4fcc417de02f7075641b53e5fc108090c6a5eec8c80c87
NTLA,2025-04-09T13:42:58+00:00,"Intellia Therapeutics, Inc. (NTLA): Among Stocks Under $10 that Will Triple",Yahoo,https://finnhub.io/api/news?id=a7e93faf759b8468b3cdd3225a495debb548bd7359d7793c790421ea41a8d4fb
NTLA,2025-04-07T05:46:20+00:00,"Class Action Filed Against Intellia Therapeutics, Inc. (NTLA) - April 14, 2025 Deadline to Join - Contact The Gross Law Firm",Finnhub,https://finnhub.io/api/news?id=e01a2785884b2d269d188125bb7b645674f43438952719ff1235cdea9217f159
NTLA,2025-04-04T12:40:04+00:00,"NTLA DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 14 Deadline in Securities Class Action - NTLA",Finnhub,https://finnhub.io/api/news?id=288a421dfdee07b48ff803718ded885a136e1a8b372c542c2afebd3d2ce707fa
NTLA,2025-04-04T11:28:58+00:00,Intellia doses first subject in trial of nex-z for hereditary ATTRv-PN,Yahoo,https://finnhub.io/api/news?id=ae63b086327def994b12a7fa2e99607f927e106dce4f589ab49c0992e3deea3b
NTLA,2025-04-03T17:21:05+00:00,"NTLA Investors Have Opportunity to Lead Intellia Therapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP",Finnhub,https://finnhub.io/api/news?id=34d578b7377116875c75c4b9ed742b67cfded791d6d39eec2867981918f99cc0
NTLA,2025-04-03T16:40:34+00:00,IO360 Summit: Improving CAR-T cell therapy manufacture and accessibility,Yahoo,https://finnhub.io/api/news?id=b58e4b6fb310654d2308b79cefcd835e1fb71983745afaeb3b4fdc4a71a33a7b
NTLA,2025-04-03T14:11:05+00:00,"NTLA Deadline: NTLA Investors with Losses in Excess of $100K Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit",Finnhub,https://finnhub.io/api/news?id=e87467b921ee4cfb38625895c9318fd08895350271d5240b92d5b6bd5468ca0b
NTLA,2025-04-03T11:30:00+00:00,"Intellia Therapeutics Announces First Patient Dosed in the MAGNITUDE-2 Phase 3 Study of Nexiguran Ziclumeran (nex-z), a One-Time Gene Editing-Based Treatment for Transthyretin (ATTR) Amyloidosis with Polyneuropathy",Yahoo,https://finnhub.io/api/news?id=8761c0b35f2836e301efa7acdd743bfc7490cac8c55e6c983ad60fa4eccbd617
NTLA,2025-04-03T05:52:23+00:00,"Intellia Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 14, 2025 to Discuss Your Rights - NTLA",Finnhub,https://finnhub.io/api/news?id=405049feccd8241e0cb0263a222daed57eb23d8d5b08416d48e2f32fb5a42c00
NTLA,2025-04-01T16:41:58+00:00,"Is Intellia Therapeutics, Inc. (NTLA) the Best Gene-Editing Stock to Buy?",Yahoo,https://finnhub.io/api/news?id=2fe30fdaff684401e3d3db927679f29f315d768e0576f41a6e9b99d91673eb5b
NTLA,2025-04-01T15:50:37+00:00,Biotech stocks slide as Marks resignation seen being negative for sector,Yahoo,https://finnhub.io/api/news?id=254d158cbf2c958ffa39dd784453958618f4931103736807bbadab76abc44dcf
NTLA,2025-04-01T05:46:23+00:00,"Shareholders that lost money on Intellia Therapeutics, Inc.(NTLA) should contact Levi & Korsinsky about pending Class Action - NTLA",Finnhub,https://finnhub.io/api/news?id=97bff268dd68c180778efc21b4117940fe62960eeb86b9945019a9552bcf91de
NTLA,2025-03-31T14:10:00+00:00,Intellia Focuses on Pipeline Development Amid Stiff Competition,Yahoo,https://finnhub.io/api/news?id=8195ef88c62076e0d29f7e1998b1800e0b7f49a7f07c30bf70afca5baf173fc1
NTLA,2025-03-31T12:44:12+00:00,"Pomerantz Law Firm Reminds Investors with Losses on their Investment in Intellia Therapeutics, Inc of Class Action Lawsuit and Upcoming Deadlines - NTLA",Finnhub,https://finnhub.io/api/news?id=6957327a6633e6a77703d4ceb84f4ca968e091a2da941e21c26c34d4ad8ce7a0
NTLA,2025-03-31T05:46:24+00:00,"Contact The Gross Law Firm by April 14, 2025 Deadline to Join Class Action Against Intellia Therapeutics, Inc.(NTLA)",Finnhub,https://finnhub.io/api/news?id=0b78fe6b8d4e6ba7c55bdc4205be38a53158e3137619c0ee6fbe787d9324bf61
NTLA,2025-03-29T09:01:04+00:00,"NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit",Finnhub,https://finnhub.io/api/news?id=14cbdf5d9e8d3e961fc6c1ea4a4dd50550d515392894dff9d7ec3bcaf4f15ccf
NTLA,2025-03-28T06:24:12+00:00,Intellia: Nex-Z Advancement Remains On Track With Expanded ATTRv-PN Indication,SeekingAlpha,https://finnhub.io/api/news?id=fd3d0a821709e20b4ebf69357265a026042c69cce7110a42e2635aee9e80c498
NTLA,2025-03-28T05:46:22+00:00,"Levi & Korsinsky Notifies Intellia Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - NTLA",Finnhub,https://finnhub.io/api/news?id=5208cb8843994109aac85666de1432ca2b3e262a1725391b4ec5fa7adbafde7d
NTLA,2025-03-27T15:36:00+00:00,NTLA Genome-Editing Therapy Gets FDA's RMAT Tag for New Indication,Yahoo,https://finnhub.io/api/news?id=0f6d81661c0c3015c1c8c5fd91eea6e715aa89295a92d5c851c3f1c157e6aa48
NTLA,2025-03-27T05:46:24+00:00,"The Gross Law Firm Reminds Intellia Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - NTLA",Finnhub,https://finnhub.io/api/news?id=bc3cdafe0cebbfb8914caff3bc2d5361f18d780484eff545ea47a7c0f746c53d
NTLA,2025-03-26T11:30:00+00:00,Intellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Nexiguran Ziclumeran (nex-z) for the Treatment of Transthyretin (ATTR) Amyloidosis with Cardiomyopathy,Yahoo,https://finnhub.io/api/news?id=06c4c1cc993501f91c2e699db9977021410a3ff27a9231117da3b13541328cf0
NTLA,2025-03-26T07:38:49+00:00,Intellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Nexiguran Ziclumeran (nex-z),Finnhub,https://finnhub.io/api/news?id=a07bff7a479d5567638811497ebddc580c792dae19c6316a414c2c986f5dee4a
NTLA,2025-03-25T09:45:05+00:00,"NTLA Investors are reminded of Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm",Finnhub,https://finnhub.io/api/news?id=d9450520ed3175dad796993302bfc2a5c0dd14239dea851fa27a990ab4aeb42f
NTLA,2025-03-24T12:38:04+00:00,"ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics",Finnhub,https://finnhub.io/api/news?id=ccf4a4770ea707a4826aacd317045ddd5f68dde0d462ba8f8126fb5560e1a04b
NTLA,2025-03-24T05:46:25+00:00,"Lost Money on Intellia Therapeutics, Inc.(NTLA)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm",Finnhub,https://finnhub.io/api/news?id=f231dabeb9fb1dbe6e6bf2f387c6cdfd3432a48caf792479c72ca77589f6efaa
NTLA,2025-03-22T08:21:05+00:00,"DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics",Finnhub,https://finnhub.io/api/news?id=af908b77a9e2b9ca7b3f5651255a9e8b42938e700751c82aea17b5306268998f
NTLA,2025-03-21T05:46:26+00:00,"Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Intellia Therapeutics, Inc. Lawsuit - NTLA",Finnhub,https://finnhub.io/api/news?id=96ad309678b604853a3a3f65b15edfcec65511cd0287f666b7b82392a1ff7b49
NTLA,2025-03-20T05:05:16+00:00,"The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Intellia Therapeutics, Inc.(NTLA) Shareholders",Finnhub,https://finnhub.io/api/news?id=9dc00f46ebe4b702820fed07adf58b628f952531f9f04b706393089182b29ef1
NTLA,2025-03-18T05:46:27+00:00,"Shareholders that lost money on Intellia Therapeutics, Inc.(NTLA) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More",Finnhub,https://finnhub.io/api/news?id=2710c8af7dbdd7141ba07a66e6b15af13f2bde511c3f561be891ff61b7946596
NTLA,2025-03-15T08:31:04+00:00,"ROSEN, A LONGSTANDING LAW FIRM, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLA",Finnhub,https://finnhub.io/api/news?id=77329633578a8c8407574b95aafd314395d5bc6860a655f6e9317f247aaca6ec
NTLA,2025-03-11T17:43:02+00:00,"Intellia Therapeutics, Inc. (NTLA) Barclays 27th Annual Global Healthcare Conference (Transcript)",SeekingAlpha,https://finnhub.io/api/news?id=944919ba5045ce78f8f8c1e46a7fcc2b920a7a86272150763c85f740dffd8e80
NTLA,2025-03-10T18:03:01+00:00,"Intellia Therapeutics, Inc. (NTLA) Leerink 2025 Global Biopharma Conference (Transcript)",SeekingAlpha,https://finnhub.io/api/news?id=1b59fb056f5ce8d32b3f5bea842a26082ba40366da04876a85671152f8c10636
NTLA,2025-03-10T05:46:27+00:00,"Intellia Therapeutics, Inc. Class Action: The Gross Law Firm Reminds Intellia Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - NTLA",Finnhub,https://finnhub.io/api/news?id=2bfbaa72e5a43590936d414284ba9f0a2c95e247cc1e40037edf1ecf5e921b69
NTLA,2025-03-07T05:54:13+00:00,"Levi & Korsinsky Notifies Shareholders of Intellia Therapeutics, Inc.(NTLA) of a Class Action Lawsuit and an Upcoming Deadline",Finnhub,https://finnhub.io/api/news?id=8c7419aa90e878a6cea74f633d1f07e514ebb14ecbde8324326768700bf89461
NTLA,2025-03-06T05:46:25+00:00,"The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Intellia Therapeutics, Inc. Lawsuit - NTLA",Finnhub,https://finnhub.io/api/news?id=6af56d497f79bf2e1f4d2310a36dae38e91c69e234aa92edf557f32dacbfa2af
NTLA,2025-03-05T14:34:08+00:00,"Royal Caribbean upgraded, AppLovin downgraded: Wall Street's top analyst calls",Yahoo,https://finnhub.io/api/news?id=69db036e5e65fee0973a485989d7e850f851b2da2216d44f01bc15d59a1653b0
NTLA,2025-03-05T11:29:17+00:00,Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(4),Finnhub,https://finnhub.io/api/news?id=f3df11e2d50864ffecd64b57622fdd3d6a29938d95fd824952f2ff78e902e95a
NTLA,2025-03-04T05:46:24+00:00,"Levi & Korsinsky Reminds Intellia Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - NTLA",Finnhub,https://finnhub.io/api/news?id=aaa9a7e7b081040a3ab973e8d402e7674303155edbfb7198e53a943501225e1c
NTLA,2025-03-03T05:46:26+00:00,"NTLA LAWSUIT ALERT: The Gross Law Firm Notifies Intellia Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline",Finnhub,https://finnhub.io/api/news?id=cb97be2497f61ea582d48c1e6b750d1e668795f1014146593e964dedc54190ec
NTLA,2025-03-02T09:30:00+00:00,Intellia Trades Lower After Q4 Results As Clinical Progress Fails To Impress,SeekingAlpha,https://finnhub.io/api/news?id=cdc973961743add6046575b23ea30cca89d313e5b3c55f11a397d7c8b094ea5b
NTLA,2025-03-01T14:04:50+00:00,"Intellia Therapeutics, Inc. (NASDAQ:NTLA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report",Yahoo,https://finnhub.io/api/news?id=d367412ad2837201e436d572c58af64460d6f1359acf23b53cee75a82aa86e59
NTLA,2025-02-28T18:24:00+00:00,"NTLA's Q4 Loss Narrower Than Estimates, Revenues Increase Y/Y",Yahoo,https://finnhub.io/api/news?id=b7115c7367b18bcfb6be67f621f9fcbcb9ed2e1f77439ec9156616199215e5df
NTLA,2025-02-28T13:00:58+00:00,Intellia Therapeutics Full Year 2024 Earnings: Beats Expectations,Yahoo,https://finnhub.io/api/news?id=77f08fd531295f821b7dbd0677167f98eed59c7ac625f8aa48382f1f8b895fff
NTLA,2025-02-28T07:10:27+00:00,Intellia Therapeutics Inc (NTLA) Q4 2024 Earnings Call Highlights: Strategic Advancements and ...,Yahoo,https://finnhub.io/api/news?id=6e9537ae7900bf50eb1a1ef4d08ecc8bd68d7d50fb795d04f438f1dc0326009d
NTLA,2025-02-28T06:17:03+00:00,Q4 2024 Intellia Therapeutics Inc Earnings Call,Yahoo,https://finnhub.io/api/news?id=fa0477b5bedc5d1c7cc5d3a559905a2ee246a49936d71b2c871a46e825d8bc1e
NTLA,2025-02-28T05:46:24+00:00,"April 14, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against NTLA",Finnhub,https://finnhub.io/api/news?id=6049aeaa3c8ad7c98889c1e4df02b6a878ba016f18004692ceb4fd94f781ef24
NTLA,2025-02-27T13:45:10+00:00,"Intellia Therapeutics, Inc. (NTLA) Reports Q4 Loss, Tops Revenue Estimates",Yahoo,https://finnhub.io/api/news?id=6af313b1cdd696b45b375c693e2fee5b60fae2b4ed009fe1638dffb7e85dc75a
NTLA,2025-02-27T12:30:45+00:00,"Intellia Therapeutics, Inc. (NTLA) Q4 2024 Earnings Call Transcript",SeekingAlpha,https://finnhub.io/api/news?id=d2530321d7691e18a3dc515ef497a8a69686b0c46351b33834e409ed50231613
NTLA,2025-02-27T12:30:00+00:00,Intellia Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Company Progress,Yahoo,https://finnhub.io/api/news?id=995681dfd6273112562979ec3045b7d1afed44864a7dc54e2b4a1d54bbbc914d
NTLA,2025-02-26T20:57:05+00:00,"Robbins LLP Reminds Intellia Therapeutics, Inc. (NTLA) Investors with Large Losses to Contact the Firm to Learn How They Can Recover for Their Losses",Finnhub,https://finnhub.io/api/news?id=21d562d8c29f2dd8dd279fc8cabb78b4bc6046781890c036d1662516cbc436cf
NTLA,2025-02-25T16:01:03+00:00,"NTLA Bronstein, Gewirtz & Grossman LLC Announces that Intellia Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit",Finnhub,https://finnhub.io/api/news?id=183eb2096cffe416dba9bf9f90dddbb38b4c1e3103f49ff0080afd9ce62ea3a4
NTLA,2025-02-25T15:00:09+00:00,"Praxis Precision Medicines, Inc. (PRAX) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release",Yahoo,https://finnhub.io/api/news?id=c36cf496be17098cf0ac7751f488fa222b981b366a17a47806df7e4fe4a0eda2
NTLA,2025-02-25T05:46:24+00:00,"Investors in Intellia Therapeutics, Inc. Should Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights - NTLA",Finnhub,https://finnhub.io/api/news?id=604645bb0354072ba3a585f3c56a75d39fc0619b8b036825cf9b7bbf7d55ac13
NTLA,2025-02-24T15:29:00+00:00,What's in Store for These 5 Biotech Stocks This Earnings Season?,Yahoo,https://finnhub.io/api/news?id=d26f90e69dca667f84b8753d2ac83104e6a8dc8653b373d96220ccbafed335f0
NTLA,2025-02-24T15:00:00+00:00,"2 Beaten-Down Stocks to Buy Before They Soar by 66% and 415%, According to Wall Street",Yahoo,https://finnhub.io/api/news?id=2ad344757a594161e17b1ba2f68e083b17e3bfbc960a48ec87d548ad538d3795
NTLA,2025-02-24T05:46:26+00:00,"Intellia Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - NTLA",Finnhub,https://finnhub.io/api/news?id=ae23de3fd5fb974442c2c02f2396117c937f9e4370a06b9ed6acea3a05128817
NTLA,2025-02-21T05:46:26+00:00,"Class Action Filed Against Intellia Therapeutics, Inc. (NTLA) Seeking Recovery for Investors - Contact Levi & Korsinsky",Finnhub,https://finnhub.io/api/news?id=2c8d0e1793d214b25a3ee5c870c574d5c81533e22990a46b8d4e3aed6a0808cb
NTLA,2025-02-20T15:00:57+00:00,"Intellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release",Yahoo,https://finnhub.io/api/news?id=05597eebe6be3cbc2de3b7b33d1dfddad8424b9c4081276fc0762f6d42116d99
NTLA,2025-02-20T14:57:00+00:00,Intellia Therapeutics (NTLA) Stock Jumps 6.5%: Will It Continue to Soar?,Yahoo,https://finnhub.io/api/news?id=36fd96b493ba174139b8d1c51ac0a43f4f0415175cceaad4369ae2369585b36d
NTLA,2025-02-20T12:30:00+00:00,Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2024 Earnings and Company Updates,Yahoo,https://finnhub.io/api/news?id=313c1125753f643b4f0dac301c5a14b9687e7a23d538e3aee55c82fc2d16fcce
NTLA,2025-02-20T10:45:05+00:00,"Faruqi & Faruqi Reminds Intellia Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - NTLA",Finnhub,https://finnhub.io/api/news?id=9a42de612d8359e216cbdb803751867fd0509e722018dbb457917e2000705085
NTLA,2025-02-20T05:46:26+00:00,"The Gross Law Firm Notifies Shareholders of Intellia Therapeutics, Inc.(NTLA) of a Class Action Lawsuit and an Upcoming Deadline",Finnhub,https://finnhub.io/api/news?id=8c7472104281d52cbb05d6a87cbc2b95ddd021726074fc139675e403e72e18c8
NTLA,2025-02-14T19:08:25+00:00,Intellia Therapeutics (NTLA): Among The Small–Cap Stocks Insiders Are Selling Recently,Yahoo,https://finnhub.io/api/news?id=b958a78a7f20cfa1639ee75995647958fce926603158f5150743c7d42be11b66
NTLA,2025-02-14T14:55:05+00:00,Does Intellia Therapeutics (NTLA) Have the Potential to Rally 422.41% as Wall Street Analysts Expect?,Yahoo,https://finnhub.io/api/news?id=2d10e021d6016ed8d2eb2549f4b6b10bf877211d0e2aa4b0f4660c9a41261637
NTLA,2025-02-07T01:10:05+00:00,Intellia Therapeutics Inc. (NTLA): Among Cathie Wood’s Top Stock Picks for 2025,Yahoo,https://finnhub.io/api/news?id=3f86d78a491f6a05c5c7fdff0e101030f4c196014e00d935d0210a33762adee8
NTLA,2025-02-05T14:14:30+00:00,"Prime Medicine: Gene Editing Company, Risky Investment",SeekingAlpha,https://finnhub.io/api/news?id=9f480daa86ad1fc8f08b5daf38d1e083a4b3936e6d2909c233d520b078d78d6f
NTLA,2025-02-04T23:56:39+00:00,Tracking Cathie Wood's ARK Invest 13F Portfolio - Q4 2024 Update,SeekingAlpha,https://finnhub.io/api/news?id=c25ea71d27140269b0430a32f361b78dc01cbd4cd622ce936110385ee5519a69
NTLA,2025-01-28T12:46:06+00:00,"Pomerantz Law Firm Investigates Claims on Behalf of Investors of Intellia Therapeutics, Inc - NTLA",Finnhub,https://finnhub.io/api/news?id=b4b4bd3f84cb9b18983825945d9f3be91eef347d2be1a8c2c3f3d48caebcc1ec
NTLA,2025-01-25T08:30:00+00:00,"Undercovered Dozen: Virgin Galactic, Gold Fields, Matador Resources, EHang +",SeekingAlpha,https://finnhub.io/api/news?id=c4ac89015287d288a823ed3de861c091c872b7853611ef7fb26abd839f1b7472
NTLA,2025-01-23T14:14:06+00:00,Intellia doses first subject in trial of NTLA-2002 for hereditary angioedema,Yahoo,https://finnhub.io/api/news?id=55b87967aed01ef2120fd540544898ce72286cb3fb057cf037658b2453b84224
NTLA,2025-01-23T05:48:11+00:00,"Intellia Therapeutics Announces First Patient Dosed in the HAELO Phase 3 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema",Finnhub,https://finnhub.io/api/news?id=63b9b3fca0b27b770b3957ab9534e619b4a4981d63c86fa20986430061603786
NTLA,2025-01-22T07:30:12+00:00,"Intellia Therapeutics Announces First Patient Dosed in the HAELO Phase 3 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema",Finnhub,https://finnhub.io/api/news?id=e88b6c38f6437254fd3698a9e0f4fdeb371cb1222553582ae0de42081640a23b
NTLA,2025-01-17T12:20:11+00:00,Editas And Intellia: Strategic Shifts And Long-Term Investment Potential,SeekingAlpha,https://finnhub.io/api/news?id=d83d27260f72d12296bc4fc25db60f01ac6c8b6450b69466a7a5750d3229a98f
NTLA,2025-01-15T19:20:34+00:00,CRISPR Therapeutics: Unfairly Punished By The Issues Of Its Peers,SeekingAlpha,https://finnhub.io/api/news?id=a458b7b0a985e00f4908707431ebb3870473dce0c8b53766225634b7777b5203
NTLA,2025-01-14T10:23:23+00:00,Intellia Therapeutics Disappointed Investors Again On January 9 (Rating Downgrade),SeekingAlpha,https://finnhub.io/api/news?id=1704c7dde012d8f755f9eacdcdde8b0260a6fe1fde3681c8f94e53814357e2dd
NTLA,2025-01-13T13:03:33+00:00,Intellia Therapeutics: Buying The Path To Commercialization,SeekingAlpha,https://finnhub.io/api/news?id=89a1ebb1ad3f0a756697c05e41fa4da710a1faad9c897d46cf8124fb15ac986b
NTLA,2025-01-10T14:56:00+00:00,"NTLA Announces Strategic Reorganization & Job Cuts in 2025, Stock Down",Yahoo,https://finnhub.io/api/news?id=7e2cf3b7aa6943bee60554706fd13c7be16ece4bd8a486eaa5f96f32af57e64a
NTLA,2025-01-10T08:58:20+00:00,"Intellia to stop work on rare disease therapy, lay off staff",Yahoo,https://finnhub.io/api/news?id=f267350f595f8f0fb351e0662bd5df759430f26d3eddb3903997c19e020959f8
NTLA,2025-01-10T08:41:26+00:00,"Intellia Therapeutics Announces Anticipated 2025 Milestones and Strategic Reorganization to Prioritize the Advancement of its Late-Stage Programs, NTLA-2002 and Nexiguran Ziclumeran",Finnhub,https://finnhub.io/api/news?id=82f313e812cf2f7771daf02c6275ba691c9d8d14a68dea18ecb06fa0c0896efe
